Open access peer-reviewed chapter

Early- Versus Late-Onset Type 1 Diabetes: Two Different Pathophysiological Subtypes with Implications for Therapy

By Willem M. Kühtreiber, Miriam Davis and Denise L. Faustman

Submitted: May 3rd 2016Reviewed: September 6th 2016Published: March 22nd 2017

DOI: 10.5772/65598

Downloaded: 529

© 2017 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Willem M. Kühtreiber, Miriam Davis and Denise L. Faustman (March 22nd 2017). Early- Versus Late-Onset Type 1 Diabetes: Two Different Pathophysiological Subtypes with Implications for Therapy, Immunopathogenesis and Immune-based Therapy for Selected Autoimmune Disorders Mourad Aribi, IntechOpen, DOI: 10.5772/65598. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="http://www.intechopen.com/embed/immunopathogenesis-and-immune-based-therapy-for-selected-autoimmune-disorders/early-versus-late-onset-type-1-diabetes-two-different-pathophysiological-subtypes-with-implications-" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

529total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Immunopathogenesis and Immune-based Therapy for Selected Autoimmune Disorders

Edited by Mourad Aribi

Next chapter

IFN-γ versus IL-17: A Battle During Cardiac Autoimmunity Evolution

By Eleonora Kurtenbach and Camila Guerra Martinez

Related Book

First chapter

Introductory Chapter: A Brief Overview on Natural Killer Cells

By Mourad Aribi

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

+3,550 Open Access Books

+57,400 Citations in Web of Science

+108,500 IntechOpen Authors and Academic Editors

+560,000 Unique visitors per month

More about us